217 related articles for article (PubMed ID: 33257316)
1. Sphingosine 1-Phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated Aplastic Anemia in a Mouse Model.
Komiya T; Gohda M; Shioya H; Katsumata S
J Pharmacol Exp Ther; 2021 Feb; 376(2):250-260. PubMed ID: 33257316
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b
Asakura T; Ishii M; Namkoong H; Suzuki S; Kagawa S; Yagi K; Komiya T; Hashimoto T; Okamori S; Kamata H; Tasaka S; Kihara A; Hegab AE; Hasegawa N; Betsuyaku T
Mucosal Immunol; 2018 Nov; 11(6):1606-1620. PubMed ID: 30116000
[TBL] [Abstract][Full Text] [Related]
3. Preventive and Therapeutic Efficacy of ONO-4641, a Selective Agonist for Sphingosine 1-Phosphate Receptor 1 and 5, in Preclinical Models of Type 1 Diabetes Mellitus.
Shioya H; Inagaki Y; Hiraizumi K; Hoshino T; Kurata H; Habashita H; Sato K; Nakade S
Biol Pharm Bull; 2021; 44(2):188-196. PubMed ID: 33518672
[TBL] [Abstract][Full Text] [Related]
4. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.
Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R
J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564
[TBL] [Abstract][Full Text] [Related]
5. Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.
Sanna K; Bruno A; Balletta S; Caioli S; Nencini M; Fresegna D; Guadalupi L; Dolcetti E; Azzolini F; Buttari F; Fantozzi R; Borrelli A; Stampanoni Bassi M; Gilio L; Lauritano G; Vanni V; De Vito F; Tartacca A; Mariani F; Rovella V; Musella A; Centonze D; Mandolesi G
Front Immunol; 2024; 15():1416133. PubMed ID: 38911847
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
7. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Salas-Perdomo A; Miró-Mur F; Gallizioli M; Brait VH; Justicia C; Meissner A; Urra X; Chamorro A; Planas AM
Sci Rep; 2019 Jun; 9(1):8309. PubMed ID: 31165772
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.
McGinley MP; Cohen JA
Lancet; 2021 Sep; 398(10306):1184-1194. PubMed ID: 34175020
[TBL] [Abstract][Full Text] [Related]
10. Siponimod in the treatment of multiple sclerosis.
Goodman AD; Anadani N; Gerwitz L
Expert Opin Investig Drugs; 2019 Dec; 28(12):1051-1057. PubMed ID: 31603362
[No Abstract] [Full Text] [Related]
11. Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.
Roderick JE; Gonzalez-Perez G; Kuksin CA; Dongre A; Roberts ER; Srinivasan J; Andrzejewski C; Fauq AH; Golde TE; Miele L; Minter LM
J Exp Med; 2013 Jul; 210(7):1311-29. PubMed ID: 23733784
[TBL] [Abstract][Full Text] [Related]
12. Exosomal sphingosine 1-phosphate secreted by mesenchymal stem cells regulated Treg/Th17 balance in aplastic anemia.
Li Y; Wang F; Guo R; Zhang Y; Chen D; Li X; Tian W; Xie X; Jiang Z
IUBMB Life; 2019 Sep; 71(9):1284-1292. PubMed ID: 30889317
[TBL] [Abstract][Full Text] [Related]
13. Panaxdiol Saponins Component Promotes Hematopoiesis and Modulates T Lymphocyte Dysregulation in Aplastic Anemia Model Mice.
Zheng ZY; Yu XL; Dai TY; Yin LM; Zhao YN; Xu M; Zhuang HF; Chong BH; Gao RL
Chin J Integr Med; 2019 Dec; 25(12):902-910. PubMed ID: 31802424
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
Chatterjee R; Law S
Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia.
Arieta Kuksin C; Gonzalez-Perez G; Minter LM
Blood; 2015 Mar; 125(13):2087-94. PubMed ID: 25647836
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis.
Komiya T; Sato K; Shioya H; Inagaki Y; Hagiya H; Kozaki R; Imai M; Takada Y; Maeda T; Kurata H; Kurono M; Suzuki R; Otsuki K; Habashita H; Nakade S
Clin Exp Immunol; 2013 Jan; 171(1):54-62. PubMed ID: 23199323
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of lymphocyte infusion-induced bone marrow failure.
Bloom ML; Wolk AG; Simon-Stoos KL; Bard JS; Chen J; Young NS
Exp Hematol; 2004 Dec; 32(12):1163-72. PubMed ID: 15588941
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.
Chen J; Feng X; Desierto MJ; Keyvanfar K; Young NS
Blood; 2015 Dec; 126(24):2621-31. PubMed ID: 26491068
[TBL] [Abstract][Full Text] [Related]
19. Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke.
Vogelgesang A; Domanska G; Ruhnau J; Dressel A; Kirsch M; Schulze J
Stroke; 2019 May; 50(5):1224-1231. PubMed ID: 31009359
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis.
Roy R; Alotaibi AA; Freedman MS
CNS Drugs; 2021 Apr; 35(4):385-402. PubMed ID: 33797705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
